Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01557881 · ClinicalTrials.gov registry record · NA
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT01557881 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 98 participants.
The verdict
NCT01557881, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
This clinical trial studies positron emission tomography (PET)/magnetic resonance imaging (MRI) in patients undergoing PET/computed tomography (CT). Diagnostic procedures, such as PET/MRI, may help doctors diagnose cancer or help doctors predict a patient's response to treatment
Interventions
- DEVICE magnetic resonance imaging with positron emission tomography scanning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01557881
The ClinicalTrials.gov registry entry for NCT01557881 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which magnetic resonance imaging with positron emission tomography scanning is the first listed.
NCT01557881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01557881 about?
NCT01557881 is a clinical study titled "Positron Emission Tomography/Magnetic Resonance Imaging in Patients". This clinical trial studies positron emission tomography (PET)/magnetic resonance imaging (MRI) in patients undergoing PET/computed tomography (CT). Diagnostic procedures, such as PET/MRI, may help doctors diagnose cancer or help doctors predict a patient's response to treatment
What is the current status of trial NCT01557881?
This trial is currently terminated. It is a NA study. The enrollment target is 98 participants. The study started on 2012-02. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01557881?
The interventions under investigation include: magnetic resonance imaging with positron emission tomography scanning (DEVICE).
Who is sponsoring clinical trial NCT01557881?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.